HOME >> MEDICINE >> NEWS
Common blood pressure drug treats muscular dystrophy in mice

Researchers at Johns Hopkins have shown that a drug commonly used to lower blood pressure reverses muscle wasting in genetically engineered mice with Marfan syndrome and also prevents muscle degeneration in mice with Duchenne muscular dystrophy. The results are reported online this week at Nature Medicine.

In 2006, a team led by Harry "Hal" Dietz, M.D., discovered that treating Marfan mice with losartan (Cozaar) dramatically strengthens the aorta, the major artery carrying blood away from the heart, and prevents enlargement and risk of bursting, a condition known as aortic aneurysm. A clinical trial to assess how effective losartan is for treating people with Marfan will launch within weeks.

"In addition to the aortic defect, children with severe Marfan syndrome often have very small, weak muscles, and adults with Marfan often can't gain muscle mass despite adequate nutrition and exercise," explains Dietz, a professor at the McKusick-Nathans Institute of Genetic Medicine at The Johns Hopkins University School of Medicine.

Dietz and his colleagues had previously discovered that many features of Marfan syndrome, including aortic aneurysm, arise from excess activity of TGF-beta, a protein that instructs cell behavior. Marfan mice have muscles containing much scar tissue between unusually small muscle fibers, which also show evidence of too much TGF-beta activity. Dietz's team reasoned that blocking the activity of TGF-beta might restore normal muscle structure and function.

First, the research team injected Marfan mice with a protein that binds TGF-beta and renders it inactive. This TGF-beta-blocking protein caused muscle fibers in these mice to grow bigger than those in untreated Marfan mice. "Not only did the muscles look bigger and better under the microscope," says Dietz, "the mice were also stronger and showed reduced fatigue."

The team then treated Marfan mice with losartan, a medication known to be safe in
'"/>

Contact: Audrey Huang
audrey@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
21-Jan-2007


Page: 1 2 3

Related medicine news :

1. Commonly used drug offers promise for premature babies
2. Commonly used pain medications do not prevent Alzheimers disease
3. Common anesthetic may induce cell death, generation of Alzheimers-associated protein
4. Common PTSD drug is no more effective than placebo
5. Common cold may be just a fingertip away due to environmental contamination
6. Commonwealth Fund commission says the US health care system needs thorough transformation
7. Commonly recommended sedative does not improve infant sleep
8. Common asthma inhaler causing deaths, researchers assert
9. Common painkillers associated with increased risk of first hospital admission for heart failure
10. Commonly used blood pressure medication prevents aortic aneurysm in mice with Marfan syndrome
11. Common osteoporosis treatment may help men with prostate cancer suffering from bone loss

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Common blood pressure drug treats muscular dystrophy mice

(Date:3/6/2015)... New York (PRWEB) March 06, 2015 “On ... dazzling days on the grand stage, to the silver screen ... sparkle throughout with precision toe-tapping numbers and their famous eye-high ... Tomczak deliver the rich history of tap dancing in this ... to come out of the United States. , “On ...
(Date:3/6/2015)... Williamsport, PA (PRWEB) March 06, 2015 ... warning of a national shortfall of 90,000 doctors by ... media, Susquehanna Health (SH) is proactively preparing ... development, recruitment and patient access. , Several factors ... population, increasing number of insured under the Affordable Care ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Jvion, ... the release of a Clostridium Difficile (C Diff) ... The C Diff use case is the latest ... span hospital acquired infections, chronic conditions, and individual ... the C Diff solution flags at risk individuals ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 Yisrayl Hawkins, ... Abilene, Texas, has released a new publication explaining how ... , The article titled “Microorganisms Do Much ... explaining how tiny microorganisms were created and designed to ... aware of some of the functions of these micro-kingdom, ...
(Date:3/6/2015)... The producers of Health Briefs TV are ... and vicinity. This is a city which is full of ... outdoor activities. It is also a city where healthcare is ... call the city home and provide care from the nearby ... program will be broadcast on CBS KLEW-TV during the month. ...
Breaking Medicine News(10 mins):Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 2Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 3Health News:Susquehanna Health Plans Progressively to Prevent Projected Physician Shortfall 4Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2Health News:Yisrayl Hawkins Tells Scientists Exactly What Makes Life Function Properly in New Publication 2Health News:The Health Briefs TV Show to Air in Spokane, Washington 2
(Date:3/5/2015)... 5, 2015  Medical Diagnostic Laboratories, L.L.C., (MDL), ... complexity, state-of-the-art, automated DNA-based molecular analyses, announces that ... testing which utilizes cutting edge technology, including next- ... approximately 12,000 women are diagnosed with cervical cancer ... Genital Human Papillomaviruses (HPV) are a group of ...
(Date:3/5/2015)... 5, 2015  AMRI (NASDAQ: AMRI ) ... newly created position of VP of International Sales, effective ... Vice President of Global Sales and Marketing. ... international sales team in an effort to increase worldwide ... segments. Mr. Pettersson will drive strategy for sales and ...
(Date:3/5/2015)... , March 5, 2015 LUNGevity Foundation, ... Food and Drug Administration,s (FDA) approval of Bristol ... and other immunotherapy treatments add another critical new ... the power of a patient,s own immune system ... been approved specifically for patients with squamous cell ...
Breaking Medicine Technology:Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3AMRI Hires VP of International Sales 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3
Cached News: